Prevalence of primary resistance to zidovudine and lamivudine in drug- naive human immunodeficiency virus type-1 infected patients: High proportion of reverse transcriptase codon 215 mutant in circulating lymphocytes and free virus

Journal of Medical Virology

Volumn 61, Issue 3, 2000, Pages 352-359

  Trabaud, Mary Anne ^a   Leriche Guerin, Karine ^b   Regis, Corinne ^a   Bordes, Isabelle ^b   Cotte, Laurent ^c   Detmer, Jill ^d   Kolberg, Janice ^d   Ritter, Jacques ^a   Trépo, Christian ^b,c  

^a UNIVERSITÉ LYON 1   (France)

^b INSERM   (France)

^c HÔTEL DIEU   (France)

^d BAYER CORPORATION   (United States)

Author keywords

Differential hybridization; Drug resistance mutations; M 184V; Proviral DNA; T215Y F; Transmission

Indexed keywords

LAMIVUDINE; RNA DIRECTED DNA POLYMERASE; ZIDOVUDINE;

ARTICLE; CODON; GENE MUTATION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYBRIDIZATION; LYMPHOCYTE; NONHUMAN; STRAIN DIFFERENCE; VIRUS LOAD; VIRUS TRANSMISSION;

ANTI-HIV AGENTS; CODON; DNA, VIRAL; DRUG RESISTANCE, MICROBIAL; HIV INFECTIONS; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; LAMIVUDINE; LYMPHOCYTES; NUCLEIC ACID HYBRIDIZATION; POLYMERASE CHAIN REACTION; PROVIRUSES; REVERSE TRANSCRIPTASE INHIBITORS; RNA, VIRAL; VIRAL LOAD; ZIDOVUDINE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0034120689     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-9071(200007)61:3<352::AID-JMV12>3.0.CO;2-R     Document Type: Article

References (23)

1. Angarano G, Monno L, Appice A, Giannelli A, Romanelli C, Fico C, Pastore G. 1994. Transmission of zidovudine-resistant HIV-1 through heterosexual contacts. AIDS 8:1013-1014.
2. Conway B, Montessori V, Rouleau D, Montaner SG, Fransen S, Shillington A, Mayers D. 1997. Primary lamivudine resistance in acute HIV infection (abstract 103). Antiviral Ther 2(Suppl 5):94-95.
3. de Ronde A, Schuurman R, Goudsmit J, van den Hoeck A, Bouscher C. 1996. First case of new infection with zidovudine-resistant HIV-1 among prospectively studied intravenous drug users and homosexual men in Amsterdam, the Netherlands. AIDS 10:231-232.
4. Eastman PS, Boyer E, Mole L, Kolberg J, Urdea M, Holodniy M. 1995. Non-isotopic hybridization assay for determination of relative amounts of genotypic human immunodeficiency virus type 1 zidovudine resistance. J Clin Microbiol 33:2777-2780.
5. Erice A, Mayers DL, Strike DG, Sannerud KJ, McCutchan FE, Henry K, Henry H, Balfour JHH. 1993. Brief report: primary infection with zidovudine-resistant human immunodeficiency virus type 1. N Engl J Med 328:1163-1165.
6. Fitzgibbon JE, Gaur S, Frenkel LD, Laraque F, Edlin BR, Dubin DT. 1993. Transmission from one child to another of human immunodeficiency virus type 1 with a zidovudine-resistance mutation. N Engl J Med 329:1835-1841.
7. Garcia-Lerma G, Soriano V, Gómez-Cano M, Bravo R, Mas A, del Romero J, Martin R, González-Lahoz J. 1996. Prevalence of zidovudine-resistant HIV-1 among rapid progressors. AIDS 10:1292-1293.
8. Hecht FM, Grant RM, Petropoulos CJ, Dillon B, Chesney MA, Tian H, Hellman NS, Bandrapalli NI, Digilio L, Branson B, Kahn JO. 1998. Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors. N Engl J Med 339:307-311.
9. Imrie A, Carr A, Duncombe C, Finlayson R, Vizzard J, Law M, Kaldor J, Penny R, Cooper DA. 1996. Primary infection with zidovudine-resistant human immunodeficiency virus type 1 does not adversely affect outcome at 1 year. Sydney Primary HIV Infection Study Group. J Infect Dis 174:195-198.
10. Ippolito G, Del Poggio P, Arici C, Gregis GP, Antonelli G, Riva E, Dianzani F. 1994. Transmission of zidovudine-resistant HIV during a bloody fight. JAMA 272:433-434.
11. Kozal M, Leahy N, Hanrahan J, Swack N, Stapleton J. 1998. Genotypic analysis of HIV-1pol genes from drug-naive patients failing antiretroviral combination therapy with reverse transcriptase inhibitors and protease inhibitors (abstract 114). Antiviral Ther 3(Suppl 1):79.
12. Larder BA, Kellam P, Kemp SD. 1991. Zidovudine resistance predicted by direct detection of mutations in DNA from HIV-infected lymphocytes. AIDS 5:137-144.
13. Leriche-Guérin K, Trabaud MA, Cotte L, Bissuel F, Deruelle E, Rougier P, Trépo C. 1997. Correlation between antiretroviral resistance mutations, biological parameters, and clinical evolution in zidovudine-treated patients infected with human immunodeficiency virus type 1. Eur J Clin Microbiol Infect Dis 16:660-668.
14. Mayers DL, Yerly S, Perrin I, Imrie A, Cooper DA, Schacker T, Corey L, Karney WW, Brown A, Rakik A, Harris R, Weislow O, Zhou S, Burke DS. 1995. Prevalence and clinical course of persons sero-converting with AZT-resistant (AZT) HIV-1 in Switzerland, Australia, and the United States between 1988 and 1994 (abstract 3921. AIDS Res Hum Retrovirus 11(Suppl 1):S162.
15. Quigg M, Rebus S, France AJ, McMenamin J, Darby G, Leigh Brown AJ. 1997. Mutations associated with zidovudine resistance in HIV-1 among recent seroconverters. AIDS 11:835-836.
16. Ruhio A, Leal M, Pineda JA, Caruz A, Luque F, Rev C, Sanchez-Quijano A, Lissen E. 1997. Increase in the frequency of mutation at codon 215 associated with zidovudine resistance in HIV-1-infected antiviral-naive patients from 1989 to 1996. AIDS 11: 1184-1186.
17. Rubio A, Leal M, Rey C, Pineda JA, Sanchez-Quijano A, Lissen E. 1998. Short-term evolution of HIV-1 viremia and CD4+ cell counts in patients who have a primary mutation to zidovudine. AIDS 12:395-398.
18. Sönnerburg A, Johansson B, Ayehunie S, Julander I. 1993. Transmission of zidovudine-resistant HIV-1. AIDS 7:1684-1685.
19. Tamalet C, Yahi N, Poizot-Martin I, Colson P, Koch N, Brun H, Gallais II, Gastaut JA. 1998. Triple-drug therapy in primary HIV-1 infection results in sustained virologic response despite initial resistance-associated mutations (abstract 89). Antiviral Ther 3(Suppl 1):61-62.
20. Vanhems P, Allard R, Cooper DA, Perrin L, Vizzard J, Hirschel B, Kinloch-de Löes S, Carr A, Lambert J. 1997. Acute human immunodeficiency virus type 1 disease as a mononucleosis-like illness: is the diagnosis too restrictive? Clin Infect Dis 24:965-970.
21. Veenstra J, Schuurman R, Cornelissen M, van't Wout AB, Boucher CA, Schuitemaker H, Goudsmit J, Coutinho RA. 1995. Transmission of zidovudine-resistant human immunodeficiency virus type 1 variants after deliberate injection of blood from a patient with AIDS: characteristics and natural history of the virus. Clin Infect Dis 21:556-560.
22. Williams JG, Kaye S, Williams DI, Bennett J, Tedder RS, Weller IVD. 1998. Antiretroviral drug-resistant genotypic mutations in HIV-infected persons at first diagnosis (1988-1997) (abstract 116). Antiviral Ther 3(Suppl 1):80.
23. Yerly S, Rakik A, Kinloch-de Loes S, Erb P, Vernazza P, Hirschel B, Perrin L. 1996. Prevalence of transmission of zidovudine-resistant viruses in Switzerland. l'Etude suisse de cohorte VIH. Schweiz Med Wochenschr 126:1845-1848.